Upregulation of soluble and membrane-bound human leukocyte antigen G expression is primarily observed in the milder histopathological stages of chronic hepatitis C virus infection

Human Immunology

Volumn 73, Issue 3, 2012, Pages 258-262

  de Oliveira Crispim, Janaina Cristiana ^a   Silva, Tarsia Giabardo Alves ^b   Souto, Francisco José Dutra ^c   Souza, Fernanda Fernandes ^d   Bassi, Carmen Lucia ^c   Soares, Christiane Pienna ^b   Zucoloto, Sérgio ^d   Moreau, Philippe ^e   Martinelli, Ana de Lourdes Candolo ^d   Donadi, Eduardo Antonio ^d  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c FEDERAL UNIVERSITY OF MATO GROSSO   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e DIF   (France)

Author keywords

Chronic hepatitis C; HLA G; Immunohistochemistry; Iron deposit

Indexed keywords

HLA G ANTIGEN;

ADULT; AGED; ARTICLE; DISEASE SEVERITY; DOWN REGULATION; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; MICROENVIRONMENT; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; VIRUS IMMUNITY;

ADULT; AGED; DISEASE PROGRESSION; DNA, VIRAL; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HLA-G ANTIGENS; HUMANS; IMMUNE EVASION; IMMUNOHISTOCHEMISTRY; LIVER; MALE; MIDDLE AGED; UP-REGULATION; YOUNG ADULT;

EID: 84857121050     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.12.004     Document Type: Article

References (22)

1. Poynard T., Yuen M.F., Ratziu V., Lai C.L. Viral hepatitis C. Lancet 2003, 362:2095-2100.
2. Rustgi V.K. The epidemiology of hepatitis C infection in the United States. J Gastroenterol 2007, 42:513-521.
3. Alter M.J. Epidemiology of hepatitis C virus infection. World J Gastroenterol 2007, 13:2436-2441.
4. Massard J., Ratziu V., Thabut D., et al. Natural history and predictors of disease severity in chronic hepatitis C. J Hepatol 2006, 44:S19-S24.
5. Erickson A.L., Kimura Y., Igarashi S., et al. The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes. Immunity 2001, 15:883-895.
6. Carosella E.D., Favier B., Rouas-Freiss N., Moreau P., LeMaoult J. Beyond the increasing complexity of the immunomodulatory HLA-G molecule. Blood 2008, 111:4862-4870.
7. Rouas-Freiss N., Gonçalves R.M., Menier C., Dausset J., Carosella E.D. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci U S A 1997, 94:11520-11525.
8. Carosella E.D., Moreau P., LeMaoult J., Rouas-Freiss N. HLA-G: from biology to clinical benefits. Trends Immunol 2008, 29:125-132.
9. Créput C., Durrbach A., Menier C., et al. Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation. J Hepatol 2003, 39:587.
10. Lozano J.M., González R., Kindelán J.M., et al. Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule. AIDS 2002, 16:347-351.
11. LeBouder F., Khoufache K., Menier C., et al. Immunosuppressive HLA-G molecule is upregulated in alveolar epithelial cells after influenza A virus infection. Hum Immunol 2009, 70:1016-1019.
12. Souto F.J., Crispim J.C., Ferreira S.C., et al. Liver HLA-G expression is associated with multiple clinical and histopathological forms of chronic hepatitis B virus infection. J Viral Hepat 2011, 18(2):102-105.
13. Martinetti M., Pacati I., Cuccia M., et al. Hierarchy of baby-linked immunogenetic risk factors in the vertical transmission of hepatitis C virus. Int J Immunopathol Pharmacol 2006, 19:369-378.
14. Cordero E.A., Veit T.D., da Silva M.A., Jacques S.M., Silla L.M., Chies J.A. HLA-G polymorphism influences the susceptibility to HCV infection in sickle cell disease patients. Tissue Antigens 2009, 74:308-313.
15. Weng P.-J., Fu Y.-M., Ding S.-X., Xu D.-P., Lin A., Yan W.-H. Elevation of plasma soluble human leukocyte antigen-G in patients with chronic hepatitis C virus infection. Hum Immunol 2011, 72:406-411.
16. Bedossa P., Poynard T. An algorithm for the grading activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996, 24:289-293.
17. Crispim J.C., Duarte R.A., Soares C.P., et al. Human leukocyte antigen-G expression after kidney transplantation is associated with a reduced incidence of rejection. Transpl Immunol 2008, 18:361-367.
18. Onno M., Pangault C., Le Friec G., Guilloux V., André P., Fauchet R. Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection. J Immunol 2000, 164:6426-6434.
19. Gazit E., Sherf M., Balbin E., Muratov A., Goldstein I., Loewenthal R. HLA-G expression is induced in Epstein-Barr virus-transformed B-cell lines by culture conditions. Hum Immunol 2007, 68:463-468.
20. Chang C.C., Murphy S.P., Ferrone S. Differential in vivo and in vitro HLA-G expression in melanoma cells: potential mechanisms. Hum Immunol 2003, 64:1057-1063.
21. Larsen M.H., Hviid T.V. Human leukocyte antigen-G polymorphism in relation to expression, function, and disease. Hum Immunol 2009, 70:1026-1034.
22. Georgopoulos N.T., Proffitt J.L., Blair G.E. Transcriptional regulation of the major histocompatibility complex (MHC) class I heavy chain, TAP1 and LMP2 genes by the human papillomavirus (HPV) type 6b, 16 and 18 E7 oncoproteins. Oncogene 2000, 19:4930-4935.